Shanthi Rexaline , Benzinga Staff Writer /November 6, 2017 Orthopediatrics Corp KIDS 4.9% is poised to achieve strong top-line growth due to its exclusive focus on the sizeable and largely underserved $2.5 billion pediatric orthopedic market, according to Stifel. Stifel initiated coverage of Orthopediatrics with a Buy rating and a $23 price target […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone